A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...

U.S. investors and pharmaceutical giants are increasingly looking to China for drug innovation, with nearly 30% of major pharma deals last year involving Chinese companies—up from 0% in 2019.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for ...

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.